Urine markers as possible tools for prostate cancer screening:: Review of performance characteristics and practicality

被引:21
作者
Müller, H [1 ]
Brenner, H [1 ]
机构
[1] German Ctr Res Ageing, Dept Epidemiol, D-69115 Heidelberg, Germany
关键词
D O I
10.1373/clinchem.2005.062919
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: In recent years, an increasing number of urine-based tests have been proposed as potential screening tests for prostate cancer. The goal of this review was to summarize the current status of evidence regarding performance characteristics of the proposed tests and their practicality under screening conditions. Method: Relevant articles published up to and including May 2005 were identified in the PubMed database. At least 10 cases and 10 controls had to be analyzed for a study to be included in the review. Data concerning the study population, performance characteristics, and the collection and processing of urine samples were extracted from the reviewed articles. Results: In all, 34 retrospective studies evaluating 21 different markers complied with the inclusion criteria. Most of the studies were rather small and included heterogeneous clinical study populations. Promising results were reported for a few markers in single studies, but they have often not been replicated in subsequent larger studies. Some of the more promising results. were obtained with 24-h urines or with specimen-handling procedures that might be difficult to perform under screening conditions. Conclusions: Larger studies with a prospective design are required to confirm promising findings regarding performance characteristics of some novel markers recently reported in mostly small studies. Future studies should also pay particular attention to the practicality of the markers under screening conditions. (c) 2006 American Association for Clinical Chemistry.
引用
收藏
页码:562 / 573
页数:12
相关论文
共 46 条
[1]   GAMMOPATHY ASSOCIATED WITH ADVANCED PROSTATE CARCINOMA [J].
ABDUL, M ;
HOOSEIN, NM .
UROLOGICAL RESEARCH, 1995, 23 (03) :185-188
[2]   URINARY TISSUE FACTOR LEVELS IN PROSTATIC-CARCINOMA - A POTENTIAL MARKER OF METASTATIC SPREAD [J].
ADAMSON, AS ;
FRANCIS, JL ;
WITHEROW, RO ;
SNELL, ME .
BRITISH JOURNAL OF UROLOGY, 1993, 71 (05) :587-592
[3]  
BREUL J, 1994, EUR UROL, V26, P18
[4]   Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging [J].
Catalona, WJ ;
Southwick, PC ;
Slawin, KM ;
Partin, AW ;
Brawer, MK ;
Flanigan, RC ;
Patel, A ;
Richie, JP ;
Walsh, PC ;
Scardino, PT ;
Lange, PH ;
Gasior, GH ;
Loveland, KG ;
Bray, KR .
UROLOGY, 2000, 56 (02) :255-260
[5]   Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination - Enhancement of specificity with free PSA measurements [J].
Catalona, WJ ;
Smith, DS ;
Ornstein, DK .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (18) :1452-1455
[6]   COMPARISON OF PROSTATE-SPECIFIC ANTIGEN CONCENTRATION VERSUS PROSTATE-SPECIFIC ANTIGEN DENSITY IN THE EARLY DETECTION OF PROSTATE-CANCER - RECEIVER OPERATING CHARACTERISTIC CURVES [J].
CATALONA, WJ ;
RICHIE, JP ;
DEKERNION, JB ;
AHMANN, FR ;
RATLIFF, TL ;
DALKIN, BL ;
KAVOUSSI, LR ;
MACFARLANE, MT ;
SOUTHWICK, PC .
JOURNAL OF UROLOGY, 1994, 152 (06) :2031-2036
[7]   Urinary 8-hydroxydeoxyguano sine and its analogs as DNA marker of oxidative stress: development of an ELISA and measurement in both bladder and prostate cancers [J].
Chiou, CC ;
Chang, PY ;
Chan, EC ;
Wu, TL ;
Tsao, KC ;
Wu, JT .
CLINICA CHIMICA ACTA, 2003, 334 (1-2) :87-94
[8]   INCREASED IMMUNODETECTION OF ACIDIC FIBROBLAST GROWTH-FACTOR IN BLADDER-CANCER, DETECTABLE IN URINE [J].
CHOPIN, DK ;
CARUELLE, JP ;
COLOMBEL, M ;
PALCY, S ;
RAVERY, V ;
CARUELLE, D ;
ABBOU, CC ;
BARRITAULT, D .
JOURNAL OF UROLOGY, 1993, 150 (04) :1126-1130
[9]   Prostate cancer molecular markers GSTP1 and hTERT in expressed prostatic secretions as predictors of biopsy results [J].
Crocitto, LE ;
Korns, D ;
Kretzner, L ;
Shevchuk, T ;
Blair, SL ;
Wilson, TG ;
Ramin, SA ;
Kawachi, MH ;
Smith, SS .
UROLOGY, 2004, 64 (04) :821-825
[10]  
Cussenot O, 2001, Eur J Intern Med, V12, P17, DOI 10.1016/S0953-6205(00)00134-5